Literature DB >> 26819445

Patient assessment of diabetes care in a pay-for-performance program.

Herng-Chia Chiu1, Hui-Min Hsieh2, Yi-Chieh Lin3, Shou-Jen Kuo4, Hao-Yun Kao3, Shu-Chuan Jennifer Yeh5, Wen-Hsin Chang6, Pi-Jung Hsiao7, Yao-Shen Chen8, Shoei-Loong Lin9, Gin-Ho Lo10, Chen-Guo Ker11, Yu-Han Hung12, Hsien-An Cheng13, Tiang-Hong Chou14, Sze-Yuan Chou15, Jao-Hsien Wang16, Chien-Fu Wang17.   

Abstract

OBJECTIVE: Few studies address quality of care in pay-for-performance (P4P) programs from the perspective of patients' perceptions. This study aimed to examine and compare the patient assessment of diabetes chronic care as perceived by diabetic patients enrolled and not enrolled in a P4P program from the patients' self-reported perspectives.
DESIGN: A cross-sectional study with case and comparison group design.
SETTING: A large-scale survey was conducted from February to November 2013 in 18 healthcare institutions in Taiwan. PARTICIPANTS: A total of 1458 P4P (n = 1037) and non-P4P (n = 421) diabetic patients participated in this large survey. The Chinese version of the Patient Assessment of Chronic Illness Care (PACIC) instrument was used and patients' clinical outcome data (e.g. HbA1c, LDL) were collected. INTERVENTION: None. MAIN OUTCOME MEASURES: Five subscales from the PACIC were measured, including patient activation, delivery system design/system support, goal setting/tailoring, problem solving/contextual and follow-up/coordination. Patient clinical outcomes were also measured. Multiple linear regression and logistic regression models were used and controlled for patient demographic and health institution characteristics statistically.
RESULTS: After adjusting for covariates, P4P patients had higher overall scores on the PACIC and five subscales than non-P4P patients. P4P patients also had better clinical processes of care (e.g. HbA1c test) and intermediate outcomes.
CONCLUSIONS: Patients who participated in the program likely received better patient-centered care given the original Chronic Care Model. Better perceptions of diabetic care assessment also better clinical outcomes. The PACIC instrument can be used for the patient assessment of chronic care in a P4P program.
© The Author 2016. Published by Oxford University Press in association with the International Society for Quality in Health Care; all rights reserved.

Entities:  

Keywords:  PACIC; chronic care model; diabetes care; patient-centered care; pay-for-performance

Mesh:

Year:  2016        PMID: 26819445     DOI: 10.1093/intqhc/mzv120

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  5 in total

1.  The association of cumulative discrimination on quality of care, patient-centered care, and dissatisfaction with care in adults with type 2 diabetes.

Authors:  David M Cykert; Joni S Williams; Rebekah J Walker; Kimberly S Davis; Leonard E Egede
Journal:  J Diabetes Complications       Date:  2016-09-30       Impact factor: 2.852

2.  Pay-for-performance and continuity of care synergistically reduced amputation of lower extremity in patients with diabetes: a population-based cohort study.

Authors:  Yu-Ching Chen; Yi-Han Liao; Li-Jung Elizabeth Ku; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2022-06-04       Impact factor: 2.908

3.  Assessment of the quality of primary care for the elderly according to the Chronic Care Model.

Authors:  Líliam Barbosa Silva; Sônia Maria Soares; Patrícia Aparecida Barbosa Silva; Joseph Fabiano Guimarães Santos; Lívia Carvalho Viana Miranda; Raquel Melgaço Santos
Journal:  Rev Lat Am Enfermagem       Date:  2018-03-08

4.  Perceived quality of care among people with type 2 diabetes mellitus in the north east region of peninsular Malaysia.

Authors:  Noorfariza Nordin; Suhaily Mohd Hairon; Najib Majdi Yaacob; Anees Abdul Hamid; Seoparjoo Azmel Mohd Isa; Norzaihan Hassan
Journal:  BMC Public Health       Date:  2021-02-02       Impact factor: 3.295

5.  Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus.

Authors:  Fang-Ping Kung; Ching-Fang Tsai; Chin-Li Lu; Li-Chung Huang; Chieh-Hsiang Lu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.